AMLX Earnings

Quarterly EPS
$0.00
Q4 2024
$-0.42
Q1 2025
$-0.46
Q2 2025
$-0.37
Q3 2025
$-0.30
Q4 2025
$-0.37
Q1 2026
$-0.39
Q2 2026
$-0.38
Q3 2026
Latest RevenueN/A
Latest Net Income-45489000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.380-45489000—-2.7%
Q2 2026-$0.390-43423000—+15.2%
Q1 2026-$0.370-41284000—+11.9%
Q4 2025-$0.300-32999000——
Q3 2025-$0.370-34386000-100.0%+65.4%
Q2 2025-$0.460-41443000+100.0%+57.0%
Q1 2025-$0.420-35907000-100.0%+76.0%
Q4 2024—————
Q3 2024-$1.07416.0K-72704000——
Q2 2024-$1.07-1023000-72700000——
Q1 2024-$1.7588.6M-118793000——
Q4 2023$0.07108.4M4.7M——
Amylyx Pharmaceuticals (AMLX) — Earnings